Observation or Radical Treatment in Patients With Prostate Cancer

NCT00499174 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2023-08-23

Study results available
· View outcomes & findings →

Summary

RATIONALE: Sometimes prostate tumours may not need treatment until they progress. In this case, observation may be sufficient. Radical treatments, such as radical prostatectomy or radiation therapy, may be effective in treating prostate cancer when it is first diagnosed. It is not yet known whether active surveillance is more effective than radical treatment as an initial intervention in favorable prognosis prostate cancer.

PURPOSE: This randomized phase III trial is studying active surveillance to see how well it works compared with radical treatment as an initial intervention in patients with favorable prognosis prostate cancer.

Conditions

Interventions

PROCEDURE

conventional surgery

Radical prostatectomy

RADIATION

brachytherapy

high dose rate temporary seed implant; permanent seed implant.

RADIATION

external beam radiation therapy

3D conformal radiation therapy; intensity modulated radiation therapy.

PROCEDURE

Biopsies

Periodic repeat biopsies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Cancer and Leukemia Group B

    collaborator NETWORK
  • Eastern Cooperative Oncology Group

    collaborator NETWORK
  • SWOG Cancer Research Network

    collaborator NETWORK
  • Radiation Therapy Oncology Group

    collaborator NETWORK
  • Institute of Cancer Research, United Kingdom

    collaborator OTHER
  • NCIC Clinical Trials Group

    lead NETWORK

Principal Investigators

  • Laurence H. Klotz, MD · Toronto Sunnybrook Regional Cancer Centre

  • Adam S. Kibel, MD · Washington University Siteman Cancer Center

  • Martin G. Sanda, MD · Beth Israel Deaconess Medical Center

  • Ian M. Thompson, MD · The University of Texas Health Science Center at San Antonio

  • Richard Choo, M.D · Mayo Clinic

  • Chris Parker, M.D · Royal Marsden Hospital, Sulton, UK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-06
Primary Completion
2011-12-31
Completion
2013-01-10

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00499174 on ClinicalTrials.gov